Gene · 2237
NIH grants2,316
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 2,316
Download this page as JSON| Grant | Title | FEN1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA030199 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA034196 | Cancer Center Support (CORE) Grant | 2 | 2025 |
| P30CA042014 | Cancer Center Support Grant | 2 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 2 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 2 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 2 | 2025 |
| P30ES023515 | Mount Sinai Center for Health and Environment Across the LifeSpan (HEALS) | 2 | 2025 |
| R01AI107301 | Genetic Viral and Host Adaptations to Breach Species Barriers of HCV | 2 | 2025 |
| R01AI168048 | Rational design and efficacy testing of vaccines against HCV | 2 | 2025 |
| R01CA163336 | Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data | 2 | 2025 |
| R01CA174904 | Roles of Chromatin Modification in BRCA1 Dependent DNA Repair | 2 | 2025 |
| R01CA195612 | Molecular modulators of radiation-induced chromosome instability and hematopoietic damage | 2 | 2025 |
| R01CA197774 | Regulation of DNA synthesis in response to DNA damage | 2 | 2025 |
| R01CA207209 | Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism | 2 | 2025 |
| R01CA214799 | Compensatory Mechanisms that Promote Homologous Recombination in BRCA1 Mutant Cancers | 2 | 2025 |
| R01CA237263 | DNA replication stress in cancer | 2 | 2025 |
| R01CA256989 | Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance | 2 | 2025 |
| R01CA279840 | Okazaki fragment maturation: mutagenesis and cell survival | 2 | 2025 |
| R01ES030575 | Function of HMCES in abasic site repair and tolerance | 2 | 2025 |
| R01GM074223 | Joint Molecule Resolution During Meiotic Recombination | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/grants?page=5